血動力学的自発的な改善または安定化,およびそれに関連する生検の発見は, kongestive cardiomyopathy の患者におけるものです
Circulation
|June 1, 1985
まとめ
kongestive cardiomyopathy (CCM) の患者のアウトカムが著しく変化しています. 心臓内膜組織生検におけるミオフィブリル体積分は,CCM患者における疾患の経過と予後を予測することができます.
科学分野:
- 心臓病学 心臓病学
- 病理学 パトロジー
背景:
- 閉塞性心筋病症 (CCM) は,患者のアウトカムが変動する複雑な心疾患です.
- CCMの臨床経過と予後を予測することは,依然として課題です.
研究 の 目的:
- 閉塞性心筋症候群の患者の血液動力学的経路を調査する.
- 疾患の進行または改善を予測するエンドミオカルディアル生検の結果を含む要因を特定する.
主な方法:
- 左心室噴出分数 (LVEF) と肺圧を含む血液動力学的パラメータは56人のCCM患者でモニタリングされました.
- エンドミオカルディアン生検は38人の患者のミオフィブリル体積分を分析した.
- 患者のアウトカム (死亡,悪化,安定化,改善) を平均32.2ヶ月間追跡した.
主要な成果:
- 患者の48%が血液動力学的悪化を経験し,24ヶ月以内に心不全で5人が死亡しました.
- 52%の患者が改善または安定した状態を示した.
- 減少したミオフィブリル体積分 (<60%) は,悪化と死亡 (96%の感度) の高度な予測力であった.
- ミオフィブリルの体積分数が高かった場合 (≥60%) は改善または安定化 (93%の特異性) を予測した.
結論:
- 個々のCCM患者コースは著しく異なります.
- エンドミオカルディアル生検からのミオフィブリル体積分は,有意な予後情報を提供します.
- ミオフィブリルの体積分数のような形態学的基準は,患者グループを区別することができ,CCMの病原性多様性を示唆します.
さらに関連する動画
14:24Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
関連する概念動画
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
